🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center,randomized,phase 3 clinical trial. In the study, HER...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-02-02
Trial ID
NCT04736589
Treatments Being Tested
By measuring the intestinal flora abundance and bacterial count of patients...
Status
Unknown
Location
China
Start Date
2021-01-18
Trial ID
NCT05030519
Treatments Being Tested
Between July 2020 and August 2024, 301 HER2-positive MBC patients from five...
Status
Completed
Location
Fujian Cancer Hospital
Start Date
2020-07-01
Trial ID
NCT06990347
Treatments Being Tested
Studies H0648g and M77001 confirmed that the combination of trastuzumab wit...
Status
Unknown
Location
Multiple Locations
Start Date
2022-12-10
Trial ID
NCT05621434
Treatments Being Tested
HER2-targeted therapy after the failure of trastuzumab treatment has become...
Status
Unknown
Location
Sun Yat Sen Memorial Hospital，Sun Yat sen University
Start Date
2020-09-09
Trial ID
NCT04681911
Treatments Being Tested
This study is to explore the efficacy and safety of the first-line treatmen...
Status
Recruiting
Location
Sun Yat sen Memorial Hospital of Sun Yat sen University Shenzhen Shantou Central Hospital
Start Date
2024-10-17
Trial ID
NCT06641544
Treatments Being Tested